Mithilesh Singh

ORCID: 0000-0003-2316-9303
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Animal Virus Infections Studies
  • Virus-based gene therapy research
  • Viral gastroenteritis research and epidemiology
  • Parvovirus B19 Infection Studies
  • Mosquito-borne diseases and control
  • Immune Response and Inflammation
  • Virology and Viral Diseases
  • Microbial infections and disease research
  • Viral Infections and Immunology Research
  • Coccidia and coccidiosis research
  • Viral Infections and Vectors
  • Salmonella and Campylobacter epidemiology
  • Immunotherapy and Immune Responses
  • Brucella: diagnosis, epidemiology, treatment
  • Veterinary medicine and infectious diseases
  • Animal Nutrition and Physiology
  • graph theory and CDMA systems
  • RNA and protein synthesis mechanisms
  • Escherichia coli research studies
  • Influenza Virus Research Studies
  • Aortic Disease and Treatment Approaches
  • Biosensors and Analytical Detection
  • Advanced Drug Delivery Systems
  • Monoclonal and Polyclonal Antibodies Research
  • Herpesvirus Infections and Treatments

Indian Veterinary Research Institute
2016-2025

The Ohio State University
2023-2025

Shree Krishna Hospital
2025

NIMS University
2024

Indian Council of Agricultural Research
2021-2024

G.B. Pant Institute of Himalayan Environment and Development
2024

Ranchi University
2023

Sami Labs (India)
2020

Steel Authority of India Limited
2014

Wilmington University
1990

We present Explainable XR, an end-to-end framework for analyzing user behavior in diverse eXtended Reality (XR) environments by leveraging Large Language Models (LLMs) data interpretation assistance. Existing XR analytics frameworks face challenges handling cross-virtuality - AR, VR, MR transitions, multi-user collaborative application scenarios, and the complexity of multimodal data. addresses these providing a virtuality-agnostic solution collection, analysis, visualization immersive...

10.48550/arxiv.2501.13778 preprint EN arXiv (Cornell University) 2025-01-23

Salmonellosis, a gastrointestinal disease, continues to be one of the major public health concerns worldwide. Poultry meat and eggs are recognized as source Salmonella food poisoning in humans. Our study evaluated protective efficacy mannose-conjugated chitosan-nanoparticle (mChitosan-NP)-based subunit vaccine, consisting immunogenic outer membrane proteins flagella Enteritidis [mChitosan (OMP+FLA)/FLA-NP], coadministered orally with potent mucosal adjuvants reduce colonization S. intestines...

10.3389/fimmu.2025.1509990 article EN cc-by Frontiers in Immunology 2025-02-03

Background: The purpose of this study was to determine the SOD in patient with diabetes and look over relation development micro macrovascular complications associated SOD. Material & Method: Serum concentrations were determined 150 patients which is divided into 3 groups. Group 1 microalbuminuria, 2 without microalbuminuria whereas health control correlation among them correlated. Result: mean value for estimation group 31.50 SD 1.31 higher when compared 31.15 10.89 36.13 15.15. p-value...

10.36106/ijsr/8504983 article EN International Journal of Scientific Research 2025-02-01

A prospective randomized controlled clinical study was conducted to determine whether antioxidant supplementation as an adjunct therapy alters hemogram, oxidative stress, serum intestinal fatty acid binding protein-2 (IFABP-2) level, fecal viral load, score (CS) and survivability in outpatient canine parvovirus enteritis (CPVE) dogs. The dogs with CPVE were one of the five treatment groups: supportive (ST) alone, ST N-acetylcysteine (ST+NAC), resveratrol (ST+RES), coenzyme Q10 (ST+CoQ10) or...

10.1016/j.vas.2023.100300 article EN cc-by-nc-nd Veterinary and Animal Science 2023-06-07

Aim:The aim of this study was to screen the suspected samples by polymerase chain reaction (PCR) and epidemiological analysis positive cases canine parvovirus type2.Materials Methods: Fecal were collected from dogs for type 2 (CPV-2) viral DNA extracted.Primers designed, PCR done with all extracted samples.Age, sex breed wise distribution analyzed.Results: Out a total 44 fecal samples, 23 found be CPV-2 developed PCR.The disease more common in Labrador male pups 3-6 months age.The percentage...

10.14202/vetworld.2014.929-932 article EN cc-by Veterinary World 2014-11-01

The development of cross-protective vaccines against the zoonotic swine influenza A virus (swIAV), a potential pandemic-causing agent, continues to be an urgent global health concern. Commercially available provide suboptimal cross-protection circulating subtypes swIAV, which can lead worldwide economic losses and poor zoonosis deterrence. limited efficacy current swIAV demands innovative strategies for next-generation vaccines. Considering that intramuscular injection is standard route...

10.3390/vaccines11111699 article EN cc-by Vaccines 2023-11-07

In this study, different parts (leaf, bark, and fruit) of Pittosporum eriocarpum were investigated to explore its chemical composition biological activities. The GC-MS analysis confirmed the presence fifty-seven, eighty-one, forty-six compounds in leaf, fruit, bark extract, respectively. important identified bioactive include 1,3,4,5-tetrahydroxy-cyclohexanecarboxylic acid (quinic acid), falcarinol, tetradecanoic acid, isopropyl myristate. Further, four polyphenolic namely p-coumaric,...

10.1080/14786419.2024.2333054 article EN Natural Product Research 2024-04-08

This study focuses on the development and characterization of an intranasal vaccine platform using adjuvanted nanoparticulate delivery swine influenza A virus (SwIAV). The employed whole inactivated H1N2 SwIAV as antigen STING-agonist ADU-S100 adjuvant, with both surface adsorbed or encapsulated in mannose-chitosan nanoparticles (mChit-NPs). Optimization mChit-NPs included evaluating size, zeta potential, cytotoxicity, a 1:9 mass ratio to NP demonstrating high loading efficacy non-cytotoxic...

10.3390/vaccines12060647 article EN cc-by Vaccines 2024-06-11
Coming Soon ...